PANNONE LOPES DEVEREAUX & O'GARA LLC

Lobbying for AMGEN · Biotechnology company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · $9,000.00 income · posted Apr 7, 2026

Lobbying activity 1

Pharmacy

Prescription drug pricing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem